How to Interpret Kirby-Bauer Disk Diffusion Results Using CLSI Breakpoints

The Kirby-Bauer disk diffusion method (also known as the Bauer-Kirby test) is a standardized antimicrobial susceptibility testing (AST) technique that uses antibiotic-impregnated paper disks placed on an agar plate inoculated with a bacterial suspension. Interpretation of results relies on measuring the diameter of the zone of inhibition around each disk and comparing that measurement to current Clinical and Laboratory Standards Institute (CLSI) breakpoint tables to categorize the isolate as Susceptible (S) , Intermediate (I) , or Resistant (R) . This method is most useful for rapidly growing aerobic and facultative anaerobic bacteria in routine clinical and teaching laboratory settings, providing a cost-effective, reproducible means of guiding antimicrobial therapy and monitoring resistance trends when breakpoints are kept current.

At a Glance

Scientific Principle of Disk Diffusion

The Kirby-Bauer method relies on the diffusion of an antibiotic from a paper disk into the surrounding agar medium, establishing a concentration gradient. After incubation, bacterial growth appears as a lawn on the agar surface, except in areas where the antibiotic concentration exceeds the minimum inhibitory concentration (MIC) for that organism. The resulting clear zone—the zone of inhibition—reflects the organism's susceptibility. The diameter of this zone is inversely related to the MIC: larger zones indicate greater susceptibility (lower MIC), while smaller or absent zones indicate resistance (higher MIC).

The relationship between zone diameter and MIC is not linear but follows a predictable pattern established through extensive population studies. CLSI breakpoints are derived from these data, incorporating pharmacokinetic/pharmacodynamic (PK/PD) parameters, clinical outcome data, and microbiological distributions. Importantly, breakpoints are not static; they are revised as resistance mechanisms emerge and clinical data accumulate. Using outdated breakpoints can lead to a considerable overestimation of susceptibility, potentially resulting in ineffective treatments [1].

Materials and Instrumentation Choices

Agar Medium

• Mueller-Hinton agar (MHA) is the standard medium for disk diffusion testing. It provides consistent cation concentrations (calcium and magnesium), low sulfonamide/trimethoprim antagonist levels, and reproducible growth conditions.
• Mueller-Hinton agar with 5% sheep blood is required for fastidious organisms such as Streptococcus pneumoniae and Haemophilus influenzae.
• Depth of agar: Pour plates to a uniform depth of 4 mm (approximately 25 mL per 100 mm plate). Too-thick agar reduces antibiotic diffusion, producing falsely small zones; too-thin agar produces falsely large zones.

Antibiotic Disks

• Use commercially prepared, CLSI-recommended disks stored according to manufacturer instructions (typically at 2–8°C with desiccant).
• Disks must be allowed to reach room temperature before opening sealed containers to prevent condensation.
• Never use expired disks; potency degrades over time, leading to unreliable results.

Inoculum Preparation

• The standard inoculum is a 0.5 McFarland turbidity standard (approximately 1–2 × 10⁸ CFU/mL for most bacteria).
• Prepare the suspension from an 18–24 hour pure culture grown on non-selective agar.
• Use sterile saline or Mueller-Hinton broth as the suspension medium.
• Why this matters: An inoculum that is too heavy produces falsely small zones (apparent resistance); an inoculum that is too light produces falsely large zones (apparent susceptibility).

Measurement Tools

• Manual: A calibrated ruler, caliper, or sliding zone-measuring device reading to the nearest millimeter.
• Automated: Image-based systems using artificial intelligence (e.g., YOLO11n models) can achieve sub-millimeter precision with a mean absolute error of 0.42 mm and categorical agreement of 94.2% [4]. These systems reduce inter-operator variability but require validation against manual measurements.

Controls: The Foundation of Reliable Results

Quality control (QC) strains must be tested daily (or per laboratory policy) to ensure the test system performs within established ranges. The most common QC strains include:

• Escherichia coli ATCC 25922: For gram-negative QC
• Staphylococcus aureus ATCC 25923: For gram-positive QC
• Pseudomonas aeruginosa ATCC 27853: For Pseudomonas QC
• Enterococcus faecalis ATCC 29212: For enterococcal QC

Each antibiotic-organism combination has a defined QC range (e.g., for ciprofloxacin with E. coli ATCC 25922, the acceptable zone diameter range is 30–40 mm). If any QC result falls outside the acceptable range, the entire day's results are invalid and must be repeated after troubleshooting.

Control decisions by laboratory type:

• Teaching laboratories: Use ATCC strains only; never use clinical isolates for QC.
• Clinical laboratories: Follow CLSI M100 guidelines for QC frequency; some antibiotics require daily QC, while others may be tested weekly if performance is consistent.

Conceptual Workflow for Interpretation

Step 1: Verify Test Validity

Before measuring any zones, confirm:

• The QC strain results are within acceptable ranges.
• The lawn of growth is confluent (not too sparse or too heavy).
• Zone margins are sharp and clearly defined (swarming organisms like Proteus spp. may require special reading rules).
• No contaminant colonies are present.

Step 2: Measure Zone Diameters

• Hold the plate against a dark, non-reflective background with reflected light.
• Measure the diameter of the complete zone of inhibition, including the disk, to the nearest millimeter.
• For swarming organisms (e.g., Proteus mirabilis), measure the zone edge where growth is inhibited, ignoring the thin veil of swarming.
• For sulfonamides and trimethoprim, measure the zone edge where there is 80% reduction in growth (ignore fine growth within the zone).
• For methicillin/oxacillin with staphylococci, examine the zone carefully for any growth within the zone; even a single colony indicates resistance.

Step 3: Select the Correct CLSI Breakpoint Table

CLSI M100 is organized by organism group. Key tables include:

• Table 2A: Enterobacterales (formerly Enterobacteriaceae)
• Table 2B: Pseudomonas aeruginosa
• Table 2C: Acinetobacter spp.
• Table 2D: Staphylococcus spp.
• Table 2E: Enterococcus spp.
• Table 2F: Streptococcus pneumoniae
• Table 2G: Haemophilus spp.

Critical warning: Always use the most current edition of CLSI M100. A retrospective study of 9,279 isolates found that outdated breakpoints caused significant misclassification, particularly for aminoglycosides against Enterobacterales (χ² = 95.27, p < 0.0001) and piperacillin-tazobactam against P. aeruginosa (χ² = 6.62, p = 0.0366) [1]. For linezolid against S. aureus, the revised 34th-edition breakpoints introduced an intermediate category, resulting in significant reclassification from susceptible to intermediate (McNemar χ² = 17.0, p < 0.0001) [1].

Step 4: Compare Zone Diameter to Breakpoint

Each antibiotic-organism combination has three breakpoint values:

• S ≥ (mm): Zone diameter at or above this value = Susceptible
• I (mm): Zone diameter within this range = Intermediate
• R ≤ (mm): Zone diameter at or below this value = Resistant

Example: For ciprofloxacin against Enterobacterales (current CLSI breakpoints):

• S ≥ 26 mm
• I = 22–25 mm
• R ≤ 21 mm

A zone of 28 mm = Susceptible; 23 mm = Intermediate; 18 mm = Resistant.

Step 5: Document and Report

Record the following for each isolate:

• Organism identification
• Each antibiotic tested and its zone diameter (mm)
• The CLSI edition used (e.g., M100 34th edition)
• The S/I/R interpretation
• QC results for the test date
• Any comments (e.g., "inducible clindamycin resistance detected" for staphylococci)

Quality Checks and Troubleshooting

Common QC Failures and Corrective Actions

Edge Cases in Zone Reading

Double zones (inner and outer rings): Some antibiotics (e.g., β-lactams with certain organisms) produce a double zone of inhibition. Read the outer edge of the inner zone (the area of complete inhibition), not the faint outer ring.

Colonies within the zone: For oxacillin/methicillin with staphylococci, any colony within the zone indicates heteroresistance and the isolate should be reported as resistant. For other antibiotics, a single colony may indicate contamination; repeat the test.

Pinpoint colonies at zone edge: For sulfonamides and trimethoprim, ignore fine growth (80% inhibition rule). For other antibiotics, pinpoint colonies at the edge may indicate a mixed culture; re-isolate and retest.

Result Interpretation and Clinical Categorization

Susceptible (S)

The isolate is inhibited by the usually achievable concentration of the antibiotic when the recommended dosage is used for the site of infection. This category implies a high likelihood of therapeutic success.

Intermediate (I)

The isolate has an MIC that approaches the usually achievable blood and tissue levels, and the response rate may be lower than for susceptible isolates. This category implies:

• The drug may be effective at higher-than-normal doses.
• The drug may be effective if concentrated at the site of infection (e.g., urine, bile).
• The isolate falls in a "buffer zone" that prevents minor technical variations from causing major interpretive errors.

Resistant (R)

The isolate is not inhibited by the usually achievable concentrations of the antibiotic with normal dosage schedules, and clinical efficacy has not been reliably demonstrated.

Special Interpretive Rules

Inducible clindamycin resistance in staphylococci: Perform a D-zone test (place clindamycin and erythromycin disks 15–20 mm apart edge-to-edge). A flattening of the clindamycin zone adjacent to the erythromycin disk indicates inducible macrolide-lincosamide-streptogramin B (MLSB) resistance. Report clindamycin as resistant even if the zone diameter alone would indicate susceptibility.

Carbapenem-resistant Acinetobacter baumannii (CRAB): Disk diffusion for tetracyclines and derivatives (doxycycline, minocycline, tigecycline) should be interpreted using current CLSI breakpoints. Studies show tigecycline maintains high susceptibility (99%) against CRAB isolates, while colistin requires broth microdilution for accurate MIC determination [2, 3].

β-lactamase testing: For Haemophilus influenzae and Moraxella catarrhalis, a positive β-lactamase test predicts resistance to ampicillin and amoxicillin, regardless of disk diffusion results.

Limitations of the Kirby-Bauer Disk Diffusion Method

1. Qualitative only: The method provides categorical results (S/I/R) but not exact MIC values. For organisms requiring precise MIC determination (e.g., vancomycin for staphylococci), broth microdilution or E-test is preferred.

2. Slow-growing or fastidious organisms: Disk diffusion is not standardized for anaerobes, mycobacteria, or most fungi. Specialized methods (e.g., agar dilution, broth microdilution) are required.

3. Breakpoint dependency: Results are only as reliable as the breakpoints applied. Using outdated CLSI breakpoints leads to significant misclassification, particularly for antibiotics with revised breakpoints [1]. Laboratories must track CLSI updates annually.

4. Polymicrobial specimens: The method requires a pure culture. Mixed infections must be resolved by subculture before testing.

5. Swarming organisms: Proteus spp., Clostridium spp., and other swarming bacteria can make zone measurement difficult, though standardized reading rules exist.

6. Methicillin-resistant staphylococci: Oxacillin disk diffusion may miss some heteroresistant strains; cefoxitin disk diffusion is preferred for detecting MRSA and MRSE.

7. Not suitable for all antibiotics: Some antibiotics (e.g., colistin) do not diffuse well in agar and require broth-based methods for accurate testing [2].

Documentation and Record Keeping

Essential Documentation Elements

• Patient/sample identifier (for clinical labs) or isolate code (for research)
• Organism identification (species level)
• Antibiotics tested (generic names preferred)
• Zone diameters (mm) for each antibiotic
• CLSI edition used (e.g., M100 34th edition, 2024)
• Interpretation (S, I, or R)
• QC strain results for the test date
• Technologist/technician initials
• Date of testing
• Any comments or deviations from standard protocol

Why Documentation Matters

Accurate documentation enables:

• Retrospective analysis of resistance trends
• Detection of laboratory errors (e.g., systematic zone measurement bias)
• Compliance with accreditation standards (CAP, CLIA, ISO 15189)
• Audit trails for quality improvement

A study of 9,279 isolates demonstrated that unregulated and delayed implementation of updated CLSI breakpoints results in significant misclassification, leading to overestimation of susceptibility and masking emerging resistance [1]. Proper documentation of the CLSI edition used is essential for interpreting historical data.

Biosafety Considerations

BSL-1 Teaching Laboratory Scope

For educational settings using non-pathogenic strains (e.g., E. coli ATCC 25922, S. aureus ATCC 25923, P. aeruginosa ATCC 27853), standard BSL-1 practices apply:

• No eating, drinking, or applying cosmetics in the laboratory
• Hand washing after handling cultures and before leaving the lab
• Decontamination of work surfaces daily and after spills
• Proper disposal of all cultures and contaminated materials (autoclaving before disposal)
• Use of lab coats and gloves

BSL-2 Considerations for Clinical Isolates

When working with clinical isolates (e.g., Acinetobacter baumannii, S. aureus from patient specimens), BSL-2 practices are required [6]:

• All manipulations performed in a biological safety cabinet (BSC)
• Restricted access to the laboratory
• Use of appropriate personal protective equipment (PPE): lab coat, gloves, eye protection
• Sharps precautions (disposal of glass Pasteur pipettes, slides)
• Autoclave all waste before disposal
• Training in biosafety procedures for all personnel

Recombinant or Synthetic Nucleic Acid Work

If the Kirby-Bauer method is used to test organisms containing recombinant or synthetic nucleic acid molecules (e.g., transformed E. coli with cloned resistance genes), the work must comply with NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. This typically requires Institutional Biosafety Committee (IBC) approval and may necessitate BSL-2 containment depending on the risk assessment.

Frequently Asked Questions

1. Why must I use the most current CLSI breakpoints instead of older ones?

Using outdated breakpoints can lead to a considerable overestimation of susceptibility, which can result in ineffective treatments [1]. CLSI revises breakpoints as new resistance mechanisms emerge, PK/PD data accumulate, and clinical outcomes are analyzed. For example, revised linezolid breakpoints for S. aureus introduced an intermediate category that reclassified many previously "susceptible" isolates as intermediate, reflecting the need for higher drug exposure [1]. Laboratories that fail to update breakpoints risk reporting false susceptibility, potentially compromising patient care.

2. How do I handle zone diameters that fall exactly on the breakpoint value?

Zone diameters that equal the breakpoint value are interpreted according to the category that includes that value. For example, if the breakpoint is S ≥ 20 mm and the zone measures exactly 20 mm, the result is Susceptible. If the breakpoint is R ≤ 15 mm and the zone measures exactly 15 mm, the result is Resistant. The intermediate range is defined as a range (e.g., 16–19 mm); values at the boundaries are included in the intermediate category.

3. Can I use automated zone-reading systems instead of manual measurement?

Yes, automated systems using artificial intelligence (e.g., YOLO11n models) can achieve high accuracy, with a mean absolute error of 0.42 mm in zone diameter prediction and categorical agreement of 94.2% [4]. However, these systems must be validated against manual measurements in your laboratory, and any system that produces results outside acceptable QC ranges must be investigated. Automated systems reduce inter-operator variability but do not eliminate the need for proper technique, current breakpoints, and QC.

4. What should I do if my QC strain fails for a specific antibiotic but passes for others?

A single antibiotic QC failure suggests a problem specific to that disk or the organism-disk interaction, not a systemic issue. Check: (1) disk expiration date and storage conditions, (2) whether the correct disk was used (some antibiotics have multiple disk potencies), (3) whether the QC strain is pure and correctly identified. If the disk appears compromised, repeat QC with a new disk from a different lot. If the problem persists, contact the manufacturer and consider testing with an alternative QC strain.

References and Further Reading

1. Goyal N, Gangar S, Ramakrishnan B, Goma M, Sj G, Das S. Impact of Outdated Clinical and Laboratory Standards Institute (CLSI) Breakpoint Implementation on Antimicrobial Susceptibility Interpretation: A Retrospective Analytical Study. 2026. PubMed ID: 41913829. https://pubmed.ncbi.nlm.nih.gov/41913829/ Demonstrates that outdated breakpoints cause significant misclassification of susceptibility, particularly for aminoglycosides, piperacillin-tazobactam, and linezolid.

2. Ahsan M, Adnan F, Khan MA, Khursheed N. Antimicrobial susceptibility of carbapenem-resistant Acinetobacter baumannii against tetracycline, doxycycline, tigecycline, minocycline and colistin: experience from a tertiary care hospital in Karachi. 2026. PubMed ID: 41491984. https://pubmed.ncbi.nlm.nih.gov/41491984/ Provides example of disk diffusion interpretation for CRAB using current CLSI breakpoints, showing tigecycline susceptibility at 99%.

3. Gupta P, Singh A, Gupta A, Singh DP, Nautiyal S. Phenotypic and Genotypic Characterization of Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii: A Cross-Sectional Study From a Tertiary Care Hospital in Western Uttar Pradesh, India. 2025. PubMed ID: 40510061. https://pubmed.ncbi.nlm.nih.gov/40510061/ Illustrates use of modified Kirby-Bauer disc diffusion for CRAB characterization and carbapenemase detection.

4. Ciftci F, Erarslan A, Rahebi J. Automatic detection and quantification of antimicrobial inhibition zones using YOLO11n with post-hoc interpretability validation. 2026. PubMed ID: 42131204. https://pubmed.ncbi.nlm.nih.gov/42131204/ Describes automated zone measurement achieving 0.42 mm MAE and 94.2% categorical agreement with CLSI breakpoints.

5. Schuetz AN, Ferrell A, Hindler JA, Humphries R, Bobenchik AM. Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions. 2025. PubMed ID: 40772786. https://pubmed.ncbi.nlm.nih.gov/40772786/ Summarizes annual CLSI M100 updates including new and revised breakpoints for gram-negative and gram-positive organisms.

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services. 2020. https://www.cdc.gov/labs/bmbl/index.html Authoritative principles for risk assessment, containment, decontamination, and microbiological laboratory practice.

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/ Institutional and biosafety framework for recombinant and synthetic nucleic acid research.

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/ Searchable collection of authoritative biomedical books and methods references.

Related Articles

• How to Interpret a Kirby-Bauer Disk Diffusion Test: Zone Diameter Measurement and CLSI Breakpoints
• Understanding CLSI Breakpoints for Disk Diffusion and MIC Interpretation
• How to Calculate the Number of Bacteria Using the Kirby-Bauer Disk Diffusion Method
• How to Perform a Kirby-Bauer Disk Diffusion Test: Protocol and Quality Control
• How to Interpret Zone Diameter Measurements in Disk Diffusion Susceptibility Testing
• Disk Diffusion Method for Antimicrobial Susceptibility Testing: Protocol and Interpretation